Thyme is recommended for breast cancer in moderation

Last updated:
Thyme is recommended for breast cancer in moderation
Thyme (Thymus vulgaris) contains numerous compounds with antioxidant, anti-inflammatory, antimicrobial, and antifungal properties. Thyme is an excellent dietary source of luteolin and ursolic acid, and a good source of apigenin, luteolin and zeaxanthin. Thyme also contains some beta-carotene, vitamin C and iron.
Luteolin has been shown to induce apoptosis in oral cancer calls, to promote cell cycle arrest and apoptosis in colon cancer cells, and to inhibit insulin-like growth factor 1 receptor signaling in prostate cancer cells. Ursolic acid has been shown to inhibit lung colonization of mouse melanoma cells. Apigenin has been shown to induce apoptosis in human skin, thyroid, gastric, liver, colon, cervical, and prostate cancer cells, and to inhibit migration and invasion of ovarian cancer cells.
A major Italian population study reported that the risk of breast cancer was reduced for increasing intake of flavones such as the apigenin and luteolin found in thyme.
Thyme components apigenin and luteolin have both been shown to induce apoptosis across a variety of breast cancer cell lines. For example, luteolin has been shown to increase programmed cell death in triple negative (ER-/PR-/HER2-) breast cancer cells and to reduce ER+/PR+ cell viability in a dose- and time-dependent manner. Luteolin has also been shown to inhibit angiogenesis (new blood vessel formation) and aromatase activity (in which androgens are converted into estrogens) in the laboratory.
Apigenin has been shown to exhibit potent growth-inhibitory effects in HER2+ breast cancer cells. Apigenin has also been shown to inhibit the growth of patient-derived triple negative organoids and sensitize triple negative cells to Adriamycin chemotherapy.
In addition, luteolin and apigenin both have been shown increase the anti-cancer effects of the chemotherapy drug Taxol (paclitaxel).
Ursolic acid has been shown to reverse multidrug resistance in breast cancer cells. For example, one study found that ursolic acid reversed resistance to Taxol (paclitaxel) in Taxol-resistant triple negative breast cancer. Another study reported that ursolic acid resensitized multidrug resistant ER+/PR+ breast cancer cells to Adriamycin. Still another study published in 2021 demonstrated that ursolic acid also increased the sensitivity of triple negative breast cancer cells to Adriamycin.
Dietary beta-carotene has been found to be inversely associated with the risk of ER+/PR+ breast cancer. Dietary carotenoids such as beta-carotene have been found to inhibit the cancer-promoting effects of both estradiol and genistein (the phytoestrogen found in soy), thereby reducing their potentially harmful effects in hormone-dependent breast cancer.
Several studies of early-stage breast cancer survivors have found that higher levels of cartenoids in the blood are associated with both lower risk of break cancer recurrence and lower risk of a new primary breast tumor. Plasma levels of retinol (a form of vitamin A that is a by-product of beta-carotene in the body) have also been found to be positively associated with breast cancer survival in postmenopausal women.
One 2020 study using a mouse model found that thyme extract inhibited the magnitude and frequency of oxytocin-induced uterine contractions more than controls, results which are suggestive but difficult to interpret in light of the relatively high doses used in the experiment (oxytocin has been shown to reduce proliferation of breast cancer cells). Based on the available evidence, the amounts of thyme normally used as a herb or spice in food probably are safe, however very frequent or highly concentrated uses (such as in thyme pesto sauce) might not be.

  • Ursolic Acid Enhances Cytotoxicity of Doxorubicin-Resistant Triple-Negative Breast Cancer Cells via ZEB1-AS1/miR-186-5p/ABCC1 Axis Cite
    Lu Q, Chen W, Ji Y, Liu Y, Xue X. Ursolic Acid Enhances Cytotoxicity of Doxorubicin-Resistant Triple-Negative Breast Cancer Cells via ZEB1-AS1/miR-186-5p/ABCC1 Axis. Cancer Biotherapy and Radiopharmaceuticals. Mary Ann Liebert Inc; 2021; 10.1089/cbr.2020.4147
  • Modulation of Autophagy in Cancer Cells by Dietary Polyphenols Cite
    Musial C, Siedlecka-Kroplewska K, Kmiec Z, Gorska-Ponikowska M. Modulation of Autophagy in Cancer Cells by Dietary Polyphenols. Antioxidants. MDPI AG; 2021; 10:123 10.3390/antiox10010123
  • Carvacrol (Origanum vulgare): Therapeutic Properties and Molecular Mechanisms Cite
    Mondal A, Bose S, Mazumder K, Khanra R. Carvacrol (Origanum vulgare): Therapeutic Properties and Molecular Mechanisms. Advanced Structured Materials. Springer International Publishing; 2020;:437-462 10.1007/978-3-030-54027-2_13
  • Luteolin suppresses androgen receptor-positive triple-negative breast cancer cell proliferation and metastasis by epigenetic regulation of MMP9 expression via the AKT/mTOR signaling pathway Cite
    Wu H, Lin J, Liu Y, Chen H, Hsu K, Lin S, et al. Luteolin suppresses androgen receptor-positive triple-negative breast cancer cell proliferation and metastasis by epigenetic regulation of MMP9 expression via the AKT/mTOR signaling pathway. Phytomedicine. Elsevier BV; 2020; 81:153437 10.1016/j.phymed.2020.153437
  • Inhibition of breast cancer stem-like cells by a triterpenoid, ursolic acid, via activation of Wnt antagonist, sFRP4 and suppression of miRNA-499a-5p Cite
    Mandal S, Gamit N, Varier L, Dharmarajan A, Warrier S. Inhibition of breast cancer stem-like cells by a triterpenoid, ursolic acid, via activation of Wnt antagonist, sFRP4 and suppression of miRNA-499a-5p. Life Sciences. Elsevier BV; 2020; 265:118854 10.1016/j.lfs.2020.118854
  • An In Vitro Evaluation of the Molecular Mechanisms of Action of Medical Plants from the Lamiaceae Family as Effective Sources of Active Compounds against Human Cancer Cell Lines Cite
    Sitarek P, Merecz-Sadowska A, Śliwiński T, Zajdel R, Kowalczyk T. An In Vitro Evaluation of the Molecular Mechanisms of Action of Medical Plants from the Lamiaceae Family as Effective Sources of Active Compounds against Human Cancer Cell Lines. Cancers. MDPI AG; 2020; 12:2957 10.3390/cancers12102957
  • Apigenin by targeting hnRNPA2 sensitizes triple-negative breast cancer spheroids to doxorubicin-induced apoptosis and regulates expression of ABCC4 and ABCG2 drug efflux transporters Cite
    Sudhakaran M, Parra MR, Stoub H, Gallo KA, Doseff AI. Apigenin by targeting hnRNPA2 sensitizes triple-negative breast cancer spheroids to doxorubicin-induced apoptosis and regulates expression of ABCC4 and ABCG2 drug efflux transporters. Biochemical Pharmacology. Elsevier BV; 2020; 182:114259 10.1016/j.bcp.2020.114259
  • Luteolin, an aryl hydrocarbon receptor ligand, suppresses tumor metastasis in vitro and in vivo Cite
    Feng J, Zheng T, Hou Z, Lv C, Xue A, Han T, et al. Luteolin, an aryl hydrocarbon receptor ligand, suppresses tumor metastasis in vitro and in vivo. Oncology Reports. Spandidos Publications; 2020; 10.3892/or.2020.7781
  • Thyme (Thymus vulgaris [Lamiaceae]) Leaves Inhibit Contraction of the Nonpregnant Mouse Uterus Cite
    Bafor EE, Kalu CH, Omoruyi O, Elvis-Offiah UB, Edrada-Ebel R. Thyme (Thymus vulgaris [Lamiaceae]) Leaves Inhibit Contraction of the Nonpregnant Mouse Uterus. Journal of Medicinal Food. Mary Ann Liebert Inc; 2020; 10.1089/jmf.2020.0076
  • Association between flavonoids, flavonoid subclasses intake and breast cancer risk: a case-control study in China Cite
    Feng X, Ho SC, Mo X, Lin F, Zhang N, Luo H, et al. Association between flavonoids, flavonoid subclasses intake and breast cancer risk: a case-control study in China. European Journal of Cancer Prevention. Ovid Technologies (Wolters Kluwer Health); 2019; 29:493-500 10.1097/cej.0000000000000561
  • Reversal of multidrug resistance in breast cancer cells by a combination of ursolic acid with doxorubicin Cite
    Zong L, Cheng G, Liu S, Pi Z, Liu Z, Song F. Reversal of multidrug resistance in breast cancer cells by a combination of ursolic acid with doxorubicin. Journal of Pharmaceutical and Biomedical Analysis. Elsevier BV; 2019; 165:268-275 10.1016/j.jpba.2018.11.057
  • Ursolic Acid Promotes the Sensitization of rhTRAIL-resistant Triple-negative Breast Cancer Cite
    MANOUCHEHRI JM, KALAFATIS M. Ursolic Acid Promotes the Sensitization of rhTRAIL-resistant Triple-negative Breast Cancer. Anticancer Research. Anticancer Research USA Inc.; 2018; 38:6789-6795 10.21873/anticanres.13050
  • An in vitro study on antimicrobial and anticancer potentiality of thyme and clove oils Cite
    El-Darier SM, El-Ahwany AMD, Elkenany ET, Abdeldaim AA. An in vitro study on antimicrobial and anticancer potentiality of thyme and clove oils. Rendiconti Lincei. Scienze Fisiche e Naturali. Springer Science and Business Media LLC; 2018; 29:131-139 10.1007/s12210-018-0672-0
  • Luteolin inhibits ER-α expression through ILK inhibition is regulated by a pathway involving Twist and YB-1 Cite
    Lin Y, Liu L, Ho C, Hung C, Way T. Luteolin inhibits ER-α expression through ILK inhibition is regulated by a pathway involving Twist and YB-1. Journal of Functional Foods. Elsevier BV; 2018; 42:75-84 10.1016/j.jff.2017.12.059
  • Cytochrome P450 CYP1 metabolism of hydroxylated flavones and flavonols: Selective bioactivation of luteolin in breast cancer cells Cite
    Wilsher NE, Arroo RR, Matsoukas M, Tsatsakis AM, Spandidos DA, Androutsopoulos VP. Cytochrome P450 CYP1 metabolism of hydroxylated flavones and flavonols: Selective bioactivation of luteolin in breast cancer cells. Food and Chemical Toxicology. Elsevier BV; 2017; 110:383-394 10.1016/j.fct.2017.10.051
  • Luteolin inhibits lung metastasis, cell migration, and viability of triple-negative breast cancer cells Cite
    Cook M, Liang Y, Besch-Williford C, Hyder S. Luteolin inhibits lung metastasis, cell migration, and viability of triple-negative breast cancer cells. Breast Cancer: Targets and Therapy. Informa UK Limited; 2016; Volume 9:9-19 10.2147/bctt.s124860
  • Phenolic Acid Composition, Antiatherogenic and Anticancer Potential of Honeys Derived from Various Regions in Greece Cite
    Spilioti E, Jaakkola M, Tolonen T, Lipponen M, Virtanen V, Chinou I, et al. Phenolic Acid Composition, Antiatherogenic and Anticancer Potential of Honeys Derived from Various Regions in Greece. PLoS ONE. Public Library of Science (PLoS); 2014; 9:e94860 10.1371/journal.pone.0094860
  • A comprehensive study on the phenolic profile of widely used culinary herbs and spices: Rosemary, thyme, oregano, cinnamon, cumin and bay Cite
    Vallverdú-Queralt A, Regueiro J, Martínez-Huélamo M, Rinaldi Alvarenga JF, Leal LN, Lamuela-Raventos RM. A comprehensive study on the phenolic profile of widely used culinary herbs and spices: Rosemary, thyme, oregano, cinnamon, cumin and bay. Food Chemistry. Elsevier BV; 2014; 154:299-307 10.1016/j.foodchem.2013.12.106
  • Evaluation of antioxidant activity, total phenols and phenolic compounds in thyme (Thymus vulgaris L.), sage (Salvia officinalis L.), and marjoram (Origanum majorana L.) extracts Cite
    Roby MHH, Sarhan MA, Selim KA, Khalel KI. Evaluation of antioxidant activity, total phenols and phenolic compounds in thyme (Thymus vulgaris L.), sage (Salvia officinalis L.), and marjoram (Origanum majorana L.) extracts. Industrial Crops and Products. Elsevier BV; 2013; 43:827-831 10.1016/j.indcrop.2012.08.029
  • Activities of Ten Essential Oils towards Propionibacterium acnes and PC-3, A-549 and MCF-7 Cancer Cells Cite
    Zu Y, Yu H, Liang L, Fu Y, Efferth T, Liu X, et al. Activities of Ten Essential Oils towards Propionibacterium acnes and PC-3, A-549 and MCF-7 Cancer Cells. Molecules. MDPI AG; 2010; 15:3200-3210 10.3390/molecules15053200